Literature DB >> 11857343

A subfraction of B220(+) cells in murine bone marrow and spleen does not belong to the B cell lineage but has dendritic cell characteristics.

Tatjana Nikolic1, Gemma M Dingjan, Pieter J M Leenen, Rudolf W Hendriks.   

Abstract

Although CD45R/B220 is commonly used as a pan-B cell marker in the mouse, not all B220(+) cells belong to the B cell lineage. Here we report the characterization of a subpopulation of B220(+)CD19(-) cells in murine bone marrow, which failed to express markers that are present in early CD19(--) B cell precursors. Instead, these cells expressed low levels of MHC class II and CD11c, which are typically found on dendritic cells (DC). Moreover, these B220(+)CD19(-)CD11c(+) cells expressed Gr-1, indicating that they are related to the recently identified murine plasmacytoid DC or their progenitors. Therefore, we evaluated surface marker expression of the B220(+)CD19(-)CD11c(+) cells in lymphoid tissues of C57BL/6 mice, recombinase activating gene-1 deficient mice, lacking mature B and T lymphocytes, and mice with a targeted disruption of the Ig H chain mu membrane exon (mu MT), lacking mature B lymphocytes. When comparing bone marrow and spleen, we found that the surface profiles of B220(+)CD19(-)CD11c(+) cells were remarkably similar, indicating that they are in a comparable maturation or activation stage in the two lymphoid compartments. In addition, the almost complete absence of peripheral B220(+) B-lineage cells in mu MT mice allowed the anatomical localization of the B220(+)CD19(-)CD11c(+) cells to the red pulp and the T cell areas in the spleen. Taken together, our findings indicate that the mouse bone marrow contains a recirculating population of B220(+)CD19(-) CD11c(+) plasmacytoid DC, the development of which is largely independent of the presence of mature T and B cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11857343     DOI: 10.1002/1521-4141(200203)32:3<686::AID-IMMU686>3.0.CO;2-I

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  13 in total

1.  B-cell reconstitution by transplantation of B220 CD117 B-lymphoid progenitors into irradiated mice.

Authors:  Susumu Kawaguchi
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

2.  Antigen processing and CD24 expression determine antigen presentation by splenic CD4+ and CD8+ dendritic cells.

Authors:  David Askew; Clifford V Harding
Journal:  Immunology       Date:  2007-10-19       Impact factor: 7.397

3.  Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development.

Authors:  Matthew A Inlay; Deepta Bhattacharya; Debashis Sahoo; Thomas Serwold; Jun Seita; Holger Karsunky; Sylvia K Plevritis; David L Dill; Irving L Weissman
Journal:  Genes Dev       Date:  2009-10-15       Impact factor: 11.361

4.  Derivation of 2 categories of plasmacytoid dendritic cells in murine bone marrow.

Authors:  Rosana Pelayo; Jun Hirose; Jiaxue Huang; Karla P Garrett; Alessio Delogu; Meinrad Busslinger; Paul W Kincade
Journal:  Blood       Date:  2005-02-22       Impact factor: 22.113

5.  C5aR expression in a novel GFP reporter gene knockin mouse: implications for the mechanism of action of C5aR signaling in T cell immunity.

Authors:  Jason Dunkelberger; Lin Zhou; Takashi Miwa; Wen-Chao Song
Journal:  J Immunol       Date:  2012-03-19       Impact factor: 5.422

6.  Immune regulation of transgene expression in the brain: B cells regulate an early phase of elimination of transgene expression from adenoviral vectors.

Authors:  Jeffrey M Zirger; Chunyan Liu; Carlos Barcia; Maria G Castro; Pedro R Lowenstein
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

7.  Use of interleukin 7 receptor-alpha knockout donor cells demonstrates the lymphoid independence of dendritic cells.

Authors:  Satoshi Takeuchi; Stephen I Katz
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

8.  Intravenous transfer of apoptotic cell-treated dendritic cells leads to immune tolerance by blocking Th17 cell activity.

Authors:  Fang Zhou; Elisabetta Lauretti; Antonio di Meco; Bogoljub Ciric; Patricia Gonnella; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Immunobiology       Date:  2013-03-01       Impact factor: 3.144

9.  Utility of antiPax5 in the diagnosis of lymphoproliferative disorders and neoplasia in mice.

Authors:  Jerold E Rehg; John P Sundberg
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982

Review 10.  Plasmacytoid dendritic cells in the eye.

Authors:  Arsia Jamali; Brendan Kenyon; Gustavo Ortiz; Abdo Abou-Slaybi; Victor G Sendra; Deshea L Harris; Pedram Hamrah
Journal:  Prog Retin Eye Res       Date:  2020-07-24       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.